tm logo
TMALIN
Live/Registered
REGISTERED

on 05 Sep 2023

Last Applicant/ Owned by

No. 218 Xinghu St., Suzhou Industry Park

Suzhou, Jiangsu

CN

215000

Serial Number

97363650 filed on 14th Apr 2022

Registration Number

7159102 registered on 05th Sep 2023

in the Principal Register

Correspondent Address

Timothy T. Wang

Timothy T. Wang

8140 WALNUT HILL LANE, SUITE 615

DALLAS, TX 75231

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

TMALIN

Vaccines; Anti-cancer preparations; Biological preparations for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for tr Read More

Classification Information


Class [005]
Pharmaceutical Products


Vaccines; Anti-cancer preparations; Biological preparations for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Cytostatics for pharmaceutical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic reagents for medicinal use; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of antibody-drug conjugate that facilitate the delivery of pharmaceutical preparations; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal preparations for anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, elixirs for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Therapeutic pharmaceutical for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Tumor suppressing agents


First Use Date in General

09th Jun 2022

First Use Date in Commerce

09th Jun 2022

Mark Details


Serial Number

No 97363650

Mark Type

No Service/Collective Mark

Attorney Docket Number

No BrightIP199

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
05th Sep 2023REGISTERED-PRINCIPAL REGISTER
05th Sep 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
04th Aug 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03rd Aug 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
03rd Aug 2023STATEMENT OF USE PROCESSING COMPLETE
03rd Aug 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
18th Jul 2023TEAS STATEMENT OF USE RECEIVED
18th Jul 2023USE AMENDMENT FILED
02th May 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07th Mar 2023PUBLISHED FOR OPPOSITION